Home » Topics » Regulatory

Regulatory
RSS

Wellbutrin XL approved for major depressive disorder

Sep. 2, 2003

Nabi submits supplemental data for Nabi-HB Intravenous BLA

Sep. 2, 2003

Once-daily Cipro XR approved for treatment of cUTIs

Sep. 2, 2003

Phase I/II trials cleared for topical PTH (7-34) in chemotherapy-induced alopecia

Aug. 26, 2003

Levitra receives FDA approval

Aug. 25, 2003

Health Canada approves Gamunex

Aug. 22, 2003

FDA approves Trileptal for children

Aug. 13, 2003

Lapdap approved by U.K. agency for treatment of P. falciparum malaria

Aug. 11, 2003

FDA approves Photofrin PDT for high-grade dysplasia in Barrett's esophagus

Aug. 6, 2003

Enbrel approved to improve physical function in RA patients

Aug. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...